Search This Blog

Thursday, September 13, 2018

Dicerna initiated at Citi


Dicerna initiated with a Buy at Citi. Citi analyst Robyn Karnauskas started Dicerna Pharmaceuticals with a Buy rating and $27 price target.
https://thefly.com/landingPageNews.php?id=2789753
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)